Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer-Reference-Cited by-同舟云学术

Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer

Published:2013-08 Issue:8 Volume:24 Page:2005-2011
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Crown J.,Kennedy M.J.,Tresca P.,Marty M.,Espie M.,Burris H.A.,DeSilvio M.,Lau M.R.,Kothari D.,Koch K.M.,Diéras V.

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/8/2005/13790097/mdt222.pdf

Reference19 articles.

1. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas;Press;J Clin Oncol,1997

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group;Marty;J Clin Oncol,2005

4. Durable complete response following chemotherapy and trastuzumab for metastatic HER2-positive breast cancer;Gullo;Ann Oncol,2012

5. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells;Konecny;Cancer Res,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy;British Journal of Cancer;2023-07-28

2. Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study;Frontiers in Oncology;2022-06-03

3. Hepatic resection for breast cancer related liver metastases: A single institution experience;Scandinavian Journal of Surgery;2022-03

4. Non-Surgical Management of Metastatic Breast Cancer and Palliative Care;Breast Cancer;2022

5. Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study;Frontiers in Oncology;2020-03-03